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ABSTRACT
Patientswith laryngeal disordersmay have severemorbidity relating to swallowing, vocalization, and
respiratory function, forwhich conventional therapies are suboptimal. A tissue-engineered approach
would aim to restore the vocal folds and maintain respiratory function while limiting the extent of
scarring in the regenerated tissue. Under Good Laboratory Practice conditions, we decellularized por-
cine larynges, using detergents and enzymes under negative pressure to produce an acellular scaffold
comprising cartilage, muscle, and mucosa. To assess safety and functionality before clinical trials, a
decellularized hemilarynx seeded with human bone marrow-derived mesenchymal stem cells and a
tissue-engineered oral mucosal sheet was implanted orthotopically into six pigs. The seeded grafts
were left in situ for 6 months and assessed using computed tomography imaging, bronchoscopy,
and mucosal brushings, together with vocal recording and histological analysis on explantation.
The graft caused no adverse respiratory function, nor did it impact swallowing or vocalization. Rudi-
mentary vocal folds covered by contiguous epitheliumwere easily identifiable. In conclusion, the pro-
posed tissue-engineered approach represents a viable alternative treatment for laryngeal defects.
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SIGNIFICANCE
This report describes the production and in vivo implantation of a biologically derived hemilarynx and
subsequent in vivo assessment and analysis under regulated Good Laboratory Practice conditions.
This study illustrates how physiological laryngeal-related functions can be retained.
INTRODUCTION
There are no satisfactory conventional solutions
for patients with end-stage laryngeal structural
disorders, which can result from traumaor cancer
resection. This has profound impact on quality of
life, especiallywith respect to swallowing, breath-
ing, and speech. Conventional solutions to ad-
vanced structural disorders of the larynx are
suboptimal. Of the 2,000 individuals diagnosed
annuallywith laryngeal cancer in theU.K., 800 un-
dergo local resection that leaves permanent de-
fects in the vocal cords and hoarseness; the 500
most advanced cases have their larynx removed
completely; the remainder undergo chemo-
radiotherapy, which achieves good cure rates
but has high morbidity, 5% mortality, and can
leave a functionless larynx [1].
A regenerative medicine solution providing
anatomical restoration of the larynx would im-
prove the results of resection (e.g., by replacing
vocal cord with vocal cord instead of fibrotic scar
tissue), avoid some laryngectomies, and lower
the threshold for selecting surgery over chemo-
radiotherapy, thus reducingmorbidity. Evidence
has shown that most of the larynx can be re-
moved with preservation of vocal and sphincter
functions, provided one side retains move-
ment (i.e., the “cricoarytenoid-nerve-muscle”
unit) [2, 3]
Regeneration of the vocal folds by various
tissue engineering approaches has been at-
tempted using synthetic hyaluronic acid-dextran
hydrogels [4] (accompanied by a foreign body re-
action), hyaluronic acid-based microgels with a
controllable degradation rate [5], and collagen
hydrogel composites [6, 7]. The consensus is that
synthetic or collagen-based composite scaffolds
experience accelerated degradation mediated
by fibroblasts, resulting in contraction of the ma-
trix. Biologically derived, decellularized acellular
matrices have also been used in a vocal-fold
injury model: Bovine-derived acellular scaffolds
were implanted in a rat model to repair bilateral
wounds created in the posterior vocal folds [8].
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Histological assessment showed an initial infiltration of inflam-
matory cells and fibroblasts, followed by remodeling of the ex-
tracellular matrix (ECM). Although advantageous with respect
to mechanical properties, composition, and architecture, these
scaffolds are capable of eliciting an immune response that re-
sults in a foreign-body reaction, depending how the initial decel-
lularized scaffold was produced. In humans, small areas of
cricoid cartilage have also been replaced using collagen sponge
combined with a synthetic mesh [9].
A limited number of tissue-engineered implants have pro-
gressed to late-phaseGood Laboratory Practice studies and fewer
to early-phase clinical trials. The larynx is a good subject for trans-
lational stem cell science: There is a defined clinical need, clinical
success in a closely related organ (i.e., trachea [10]), and the cells
used have limited requirements for immediate tissue perfusion.
The availability of tissue-engineered partial laryngeal implants
would also transform the treatment of the patients with advanced
trauma to the larynx, where long-term tracheostomy is presently
the only option for many. Laryngeal allo-transplantation may offer
an option for some in the future [11], but unlike the treatment pro-
posed here, it requires immunosuppression.
The tissue generated in this study was not fully functional in
that we did not replace muscle and nerve. However, the clinical
need does not necessarily demand this, because we did not re-
place the whole larynx. We proposed that this technology would
provide functional replacement in terms of airway, voice, and
swallowing in a manner superior to that provided by present
techniques.
MATERIALS AND METHODS
Regulatory Guidelines
This study was carried out in accordance with the Animal (Scien-
tific Procedures) Act 1986, which conforms to the European
Convention for the Protection of Vertebrate Animals Used for
Experimental and Other Scientific Purposes. In addition, this
study was performed in compliance with the Good Laboratory
Practice Regulations 1999 (Statutory Instrument no. 3106) and
is in conformity with, and implements the requirements of, Euro-
pean Union directives 2004/09/EC and 2004/10/EC. It was
designed after consultation with the U.K. Medicines and Health-
care Products Regulatory Agency to provide data suitable for sub-
mission for a Clinical Trials Authorization.
Study Design
Six femaleWhite/Landrace cross-bred pigs, 3–4months old, were
brought into the facility and allowed to acclimatize for 2 weeks
before any surgical procedure. Each animal was given a unique
identification number (412–417). The average body weight of
the animals at the first surgical procedure was between 43 and
55 kg. Each immune-suppressed pig received a full-thickness seg-
mentof decellularized larynx in a two-stepproceduredirectly into
a defect created in the larynx. Each decellularized hemilarynx
was initially seededwithhumanmesenchymal stemcells (MSCs)
and implanted into a sternomastoid muscle fascial pocket for
1 month (stage 1). Thereafter, the scaffold was relocated into
a full-thickness defect created in the cricoid cartilage. However,
at this stage, the luminal aspect of the scaffoldwas coveredwith
a tissue-engineered oralmucosal sheet consisting of humanoral
epithelial cells and oral fibroblasts seeded onto an acellular hu-
man dermal matrix (stage 2).
Animals were recovered and monitored for an additional
6months. One pig was killed early because of an ear infection
relating to a long-term underlying pathology exacerbated by
immunosuppression.
Biological Scaffold
Decellularized pig hemilarynges were produced using a patented
protocol developed in-house. Larynges were harvested from pigs
fromunrelated studies thatwere killed to implement refinement,
reduction, and replacement (“the 3Rs”).
Each larynx was initially frozen for 24 hours at 220°C and
then completely thawed at room temperature. The entire
decellularization process was carried out using a small desic-
cator (Sigma-Aldrich, Gillingham, Dorset, U.K., http://www.
sigmaaldrich.com). To create a vacuum, a desiccator was at-
tached to a Telstar Vacuum Pump 2F-10 (Pendle Refrigeration
Wholesale, Burnley,U.K., http://pendle-refrig.com) fittedwith a
digital vacuum gauge (Pendle Refrigeration Wholesale). A vac-
uum was created to a level of ,1 kPa absolute. The desiccator
was then placed into a shaking incubator (100 rpm) at either 4°C
or 37°C, depending on the temperature requiredwithin the pro-
tocol. All solutions used during the decellularization process
contained 1% penicillin/streptomycin (Sigma-Aldrich).
Briefly, the thawed tissue was incubated in 50 nmol/L
latrunculin B (Sigma-Aldrich) in high-glucose Dulbecco’s modi-
fied Eagle’s medium (Thermo Fisher Scientific Life Sciences,
Waltham, MA, http://www.thermofisher.com) for 2 hours at
37°C. All further steps were performed at room temperature.
Each larynx was washed in distilled water twice for 15 minutes
between incubation steps. The tissue was then incubated in
0.6 mol/L potassium chloride (Sigma-Aldrich) for 2 hours, fol-
lowed by 1.0 mol/L potassium iodide (Sigma-Aldrich) for 2 hours,
and then left to wash overnight in distilled water. The following
morning, the potassium chloride and potassium iodide incuba-
tions steps were repeated, followed by incubation in 1 Kunitz
unit (KU)/ml DNase I (Sigma-Aldrich) for 2 hours. After another
wash in distilledwater, twice for 15minutes, the tissuewas sub-
jected to another freeze (220°C) and thaw cycle for 24 hours.
Tissue was thawed at room temperature for 24 hours and
then incubated in a detergent solution containing 0.25% Tri-
ton X-100 (Sigma-Aldrich), 0.25% sodium deoxycholate (Sigma-
Aldrich) in phosphate-buffered saline solution (PBS) at 37°C for
24 hours. The tissue was then washed twice over 48 hours with
sterile water (Baxter, Deerfield, IL, http://www.baxter.com) at 4°C.
After washing, the tissue was incubated with 2,000 KU/L DNase
(Sigma-Aldrich) and 0.1 g/L RNase (Roche, Basel, Switzerland,
http://www.roche.com) at 37°C for 24 hours to solubilize any
remainingnuclear content.Aftera further24hoursofwashingwith
sterile water (Baxter) at 4°C, the DNase/RNase step was repeated
once more. The decellularization protocol was concluded with an
intensive wash using sterile water over 48–72 hours.We validated
successful decellularization of each larynx by histological and mo-
lecular analysis, and biomechanical testing.
Molecular Analysis
The GenElute mammalian genomic DNA miniprep kit (Sigma-
Aldrich) was used for DNA extraction and quantification follow-
ing the manufacturer’s instructions. The Blyscan GAG assay kit
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(Biocolor, Carrickfergus, U.K., http://www.biocolor.co.uk) was
used to quantify sulfated glycosaminoglycan content of fresh
and decellularized larynx samples (muscle and cartilage compo-
nents separately). The collagen content of fresh and decellular-
ized larynx (cartilage and muscle) was quantified with the Sircol
collagen assay kit (Biocolor). Adetaileddescription for each is pre-
sented in the supplemental online data.
Biomechanics
The specimens were subjected to uniaxial tension until failure,
confirmed by the loss of load and the appearance of tears in
the tissue. For each test, a sample of muscle and cartilage from
both the fresh and decellularized larynges was used. Specimens,
in the form of flat rectangular pieces with a maximum length of
33 mm, were clamped into sample holders and loaded at a con-
stant tension rate of 100mmperminute and amaximum force of
500 N. The tests were performed with the application of uniaxial
tension with an Instron In-Spec 2200 Benchtop Portable Tester
(Instron, Norwood,MA, http://www.instron.us) at room temper-
ature. The tensile tester recorded in real-time the load and the
elongation to which the tissue was subjected. Parameters such
as maximum force (N), rupture force (N), and extension at max-
imum load (mm) were recorded. The ratio of stress to strain
was calculated (Young’smodulus), which is ameasure of the stiff-
ness of an elastic material. After decellularization, the cricoid
cartilage component, together with the overlying muscle and
mucosal layer, was trimmed to an approximate size of 6 cm3
4 cm 3 2 cm (Fig. 1A, 1B).
HumanBoneMarrow-DerivedMesenchymal Stem Cells
Human bone marrow-derived mesenchymal stem cells (BM-
MSCs) were obtained from bone marrow aspirates of patients
whoweredonatingBM for therapeuticMSC isolation and culture,
and who had consented to the use of excess cells for research.
They were isolated by plastic adherence before adherent culture
in media supplemented with fetal calf serum for a minimum of
three and a maximum of seven passages. Cells were split when
theywere.70% confluent by trypsinization and replating at ap-
proximately 1,000 cells per cm2. We seeded each hemilarynx by
using a custom-built bioreactor at a seeding density of 1.5 3
105/cm2. Human BM-MSCs were suspended in the smallest vol-
ume of medium and seeded directly onto the cartilaginous sur-
face and left to attach for 30 minutes in a humidified CO2
incubator. Following attachment, 50 ml of warmed medium
was added (sufficient to submerge the seeded scaffold) and left
in the humidified CO2 incubator until required.
Tissue-Engineered Oral Mucosal Sheet
Using a previously published method [12], a sheet of three-
dimensional (3D) tissue-engineered allogeneic human oral mu-
cosa (approximately 300–600mm thickness) was produced using
Figure 1. Surgical implantation. (A): The size of the implant is illustrated on a nondecellularized hemilarynx. (B): Explanted host thyroid car-
tilage and the implanted piece of decellularized larynx. Tissue-engineered oral mucosal sheet before implantation (C) and sutured onto the
luminal aspect of the implanted scaffold at stage 2 (D). (E): Closure of the overlying decellularized cricoid cartilage.
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split thickness human dermis. Each sheet of donor glycerolized
skin (Euroskin)waswashed in several changesof PBSbeforebeing
soaked in 1M sodium chloride overnight at 37°C followed byme-
chanical removal of the epidermis. The de-epidermized dermis
(DED) was washed in PBS and then stored at 37°C in medium
for 2–3 days to verify sterility. The decellularized human alloder-
mis was then ready to be seeded with human oral keratinocytes
(380,000 per cm2) and human fibroblasts (125,000 per cm2) at
37°C for 2 days in 10% Green’s media. The DED and oral cells were
cocultured for 14 days at an air-liquid interface using a floating
sterile plastic grid (Fig. 1C) [12].
Surgical Implantation
Stage 1: Intramuscular Implantation of
Laryngeal Replacement
One day before the surgical procedure (stage 1), each animal was
given the immune-suppressive drug cyclosporine 10 mg/kg (Neo-
ral; Novartis, Frimley, U.K., https://www.novartis.co.uk), which
they continued to receive daily for 80 days. The dose given was
based on previous in-house experience and blood analysis. On
thedayofsurgery,eachpigwaspremedicated intramuscularlywith
ketamine (5 mg/kg; Zoetis, Florham Park, NJ, https://www.zoetis.
com) and xylazine (1 mg/kg; Bayer UK, Newbury, U.K., https://
www.bayer.co.uk), both obtained via the National Veterinary Ser-
vice (Stroke on Trent, U.K.). General anesthesia (GA) was induced
with isofluraneover oxygenandnitrousoxide. After intubation, an-
esthesia was maintained with isoflurane. Cefuroxime 750 mg
(Flynn Pharma, Stevenage, U.K., http://www.flynnpharma.com)
was given intravenously; subcutaneous analgesia (carprofen
4 mg/kg [Rimadyl]; National Veterinary Services, Stoke-on-Trent,
U.K.,http://www.vetwholesaler.co.uk/), subcutaneousanthelmintic
(ivermectin, 1-ml standard dose; Merial, Athens, GA, http://merial.
com), andhypromellose eyedrops (FDC International, Dubai, United
Arab Emirates, http://www.fdcinternational.com) were given.
The neckwas extended and amidline incision (approximately
3–5cm)wasmade through the skin fromthemandibular region to
approximately 15 cm above the manubrium sterni. For pig 412,
the right sternomastoid muscle was prepared to provide numer-
ous small feeder vessels from the lateral side. For pigs 413–417, a
pocket was created using the sternomastoid muscle and the ad-
jacent fascia. Themusclewas prepared to provide an active blood
supply and the scaffold was inserted into the pocket such that
the seeded side of the scaffold was in contact with the prepared
muscle. The pocket was closed using 4-0 Vicryl sutures (Ethicon
UK,Wokingham, U.K., http://gb.ethicon.com). The overlying skin
was closed using 2-0 Prolene sutures (Ethicon UK) and veteri-
nary wound powder (Battles UK) and plastic skin were applied
topically.
Stage 2: Relocation of Seeded Laryngeal Replacement
Into the Larynx
Each animal was given a GA as described. Amidline incision using
the same approach as used in stage 1 was made. The sternothy-
roid muscles were separated and an incision made in the thyroid
cartilage down to the cricothyroid membrane. A rectangular
piece of a cricothyroid cartilage (of a size similar to the implanted
scaffold [Fig. 1B]), togetherwith theunderlying soft tissue and the
tip of the vocal folds, was removed, taking care to leave the re-
mainder of the arytenoid cartilage and the conus elasticus intact.
The seeded-implanted de-cellularized scaffold was assessed
visually, and the luminal side of the scaffoldwas scraped to create
a vascularized interface by making it bleed before a tissue-
engineered oral mucosal sheet was sutured with 4/0 Vicryl (Ethi-
con UK) to the luminal aspect of the scaffold (Fig. 1D). The entire
scaffold was parachuted into place; the mucosal aspect of the
graft was sutured to the opposing side with 3-0 Vicryl sutures
(Ethicon UK), taking care not to disrupt the sutured oral mucosal
sheet. The cartilagewas sutured intoplacewith4-0Vicryl (Ethicon
UK) (Fig. 1E) and the skin closed, as described.
In Vivo Assessment
Vocal Recordings
Before any surgical intervention, a 2- to 3-minute vocal recording
of each animal was made; this was repeated at 8 weeks and
4 months after stage 2 and immediately before termination of
the study. Each recordingwasmadeusing a handheld Tascam Lin-
ear PCM recorder (DR-07MKII; Tascam Teac Professional, Monte-
bello, CA, http://tascam.com). The data were initially cleaned up
using the Audacity software (http://audacityteam.org) such that
only clearly identifiable “squeals or grunts”were put forward for
further analysis. The final data set fromeach animal was analyzed
for frequency versus intensity of the waveform over the duration
of the study for each animal.
Bronchoscopic Evaluation
A bronchoscopic assessment under spontaneous ventilation of
the luminal aspect of the larynx containing the implanted scaffold
wasundertaken togetherwith amucosal brushing foreachanimal
at 2 and 4 weeks and at 2 and 6 months.
Blood and Serum Analyses
A blood sample was also taken at 2 and 4 weeks and at 2 and
6 months for each animal for full hematology, biochemistry, and
coagulation analyses. Additional blood serum analysis for inter-
leukin (IL)-6 (porcine specific IL-6 enzyme-linked immunosorbent
assay [ELISA] kit, catalog no. ab100755; Abcam, Cambridge, U.K.,
http://www.abcam.com) and IL-10 (swine-specific KSC0101;
Thermo Fisher Scientific Life Sciences, Waltham, MA, http://
www.thermofisher.com) were performed using commercially
available ELISA kits, following the manufacturers’ instructions.
Mucosal Brushing
To identify the human cells on the tissue-engineered (TE) oralmu-
cosal sheet, we used two different anti-humanMHC-1 antibodies
(purified HLA-ABC monoclonal antibody [mAb], clone W6/32,
product code 311402, BioLegend, London, U.K., http://www.
biolegend.com; and anti-HLA mAb clone EP1395Y, catalog no.
ab 52922, Abcam) and anti-human a-GAL (a-GAL epitope mAb
cloneM86, catalog no. ALX-801-090-1; Enzo Life Sciences, Exeter,
U.K., http://www.enzolifesciences.com).a-GAL staining was per-
formed under the following parameters: antigen retrieval: pro-
teinase K for 1 minute, nonspecific block with 2% BSA for
30 minutes, and 1:50 dilution for 2 hours. To further characterize
the cells, we stained the mucosal brushing with an anti-human
cytokeratin marker (mouse monoclonal anti-human CK-7-clone
OV-TL12/30 [Agilent Technologies, Ely, U.K., http://www.agilent.
com] at 1:50 for 30 minutes, no antigen retrieval).
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Explantation of the Scaffold, and Tissue Assessment
Explantation and CT Imaging
Following termination, the operative site was carefully dissected
and the entire larynx and a portion of the tracheawere explanted
and CT imaged (Innova 4100; GE Healthcare, Little Chalfont, U.K.,
http://www3.gehealthcare.com) toproduce a3D rendition of the
entire larynx, with the specific aim to locate the implanted decel-
lularized scaffold.
Histology
Each larynx was cut longitudinally on the posterior aspect,
reflected open to obtain an internal view, and photographed.
The entire larynx was placed into 10% neutral buffered formal sa-
line. After adequate fixation, each larynx was bisected (proximal
todistal) off themidlineon the contralateral side to the implanted
scaffold (i.e., on the control side). Each scaffold was cut at 0.5-cm
intervals, starting at the distal (tracheal) end toward the proximal
(thyroid cartilage). Each segment was placed into a histology cas-
sette andprocessed toparaffinwaxblocks by routine procedures.
Eachblock underwentmicrotomy toproduce sections 5mmthick.
Sectionswere stainedwithhematoxylin andeosin, andPicrosirius
red with Miller’s elastin.
Immunohistochemical Analysis
Tissue sections were stained with following antibodies: a-smooth
muscle actin (1:4,000 for 1 hour; mouse mAb, clone: 1A4, Sigma-
Aldrich); collagen II (catalog no. Abcam 3092 [Abcam]; mouse
mAb;antigenretrieval:DakoTarget retrieval [AgilentTechnologies],
incubation 1:100 for 2 hours); collagen X (catalog no. Abcam49945,
mouse mAb [Abcam]; antigen retrieval: pH 6 citrate buffer for
20 minutes, incubation at 1:200 overnight); aggrecan (anti-aggrecan
ARGxx antibody, mAb, clone BC-3, catalog no. Ab 3773 [Abcam], an-
tigen retrieval: proteinase K for 2 minutes, incubation at 1:200 over-
night); and CD 44 (catalog no. Abcam 1119863, rat mAb, antigen
retrieval: citrate buffer for 10 minutes, incubation at 1:100 for
1hour). Theprotocol canbe found in the supplemental onlinedata.
In Situ Hybridization for Alu Detection
A commercially available kit was used for the detection of Alu
sequence as an indicator for the presence of human cells
(Rembrandt In Situ and Hybridization and Detection Universal
DISH & HRP detection kit, catalog no. A001K.0101, PanPath,
Budel, The Netherlands, http://www.panpath.nl). Details can be
found in the supplemental online data.
Statistical Analysis
Data (biomechanics,moleculardata, andbloodserumanalysis)were
calculated as mean6 SE, and significance was determined by per-
forming two-tailed Student’s t tests (Prism 5; GraphPad Software,
La Jolla, CA, http://www.graphpad.com), followed by Bonferroni
asaposthoc test (molecularandbloodserum)oranalysisofvariance
(biomechanics). Ap valueof less than .05was considered significant.
RESULTS
Negative Pressure-Assisted Decellularization of
Porcine Larynx
Our decellularized larynx was completely free of all cellular
and nuclear material. Histological evaluation showed good
preservation of tissue architecture and morphology of thyroid
and cricoid cartilages, glandular tissue, muscle, and fine arterial
elastin (Fig. 2A–2F). DNA content within muscle and cartilage
was less than 50 ng/mg of tissue (Fig. 2G). Analysis of the ECM
and its GAG content revealed a decrease, with 52% retention in
the cartilage (cricoid and thyroid) and 46% in the muscle bundles
(Fig. 2H). Quantitative collagen analysis showed a significant de-
crease of approximately 50% for cartilage and muscle. Histologi-
cal evaluation under polarized light showed good structural
integrity of collagen located within the cartilage and surrounding
tissue (Fig. 2F). Biomechanical testing showed no significant dif-
ference between fresh and decellularized cartilage; however, a
significant weakening of the muscle was noted (Fig. 2).
In Vivo Assessment of the Seeded Graft
This study was designed to provide long-term evidence of safety
and efficacy of a seeded decellularized scaffold for partial laryn-
geal replacement. There were no clinical adverse effects due to
the implanted scaffold; one pigwas killed because of an ear infec-
tion relating to a long-term underlying pathology exacerbated by
immunosuppression. We saw no significant change in serum lev-
els in either IL-10 or IL-6 over the duration of the study (Fig. 3B).
The implanted scaffold provided a framework for tissue regener-
ation with good functional (i.e., airway; swallowing, which was
not formally assessed, although feeding habit as part of the daily
husbandry assessmentwasmonitored togetherwithweight gain)
and vocal results.
We examined each animal over the course of the study to as-
sess the macroscopic appearance of the mucosal surface on the
operated side and thepotential regeneration of the vocal folds. At
the first bronchoscopy examination (2 weeks), a slightly inflamed
but well-vascularized mucosal surface was seen in each animal
(Fig. 3B). In animal 417, there was closure due to swelling, but
without tissue integration, at the anterior commissure. The mac-
roscopic appearance of the implanted side did not differ from the
contralateral (control) side in any animal. However, in all animals,
we noticed the presence of a white material (possibly the
implanted oral mucosal sheet), which had accumulated at the
anterior commissure. This persisted, although it was reduced in
amount at 4weeks. By 6months thewhitematerial was only pre-
sent in animal 414. Vocal fold-like features developed in each an-
imal on the implanted side, although cranial to the normal cords
on the opposite side. These folds were initially seen at 4 weeks as
a depression and contouring of the mucosal surface, but by
6 months, they were well-defined fold-like features.
We could not identify human oral mucosal cells and the cell
smears showed no positivity for human epithelial cells by CK7
staining, nor were any human cells of any phenotype identified
with anti-human MHC-1 (data not shown) or anti-human a-GAL
antibody. Porcine cells within the cell smears were positive for
anti-human a-GAL (Fig. 3C) as early as 2 weeks after implantation.
For the vocalization analysis, qualitatively, we noticed a gen-
eral hoarseness accompanied by an exaggerated roughness of
varying degrees for each animal. Quantitatively, in four of the
six animals, there was a shift in the peaks in the spectrogram of
peak energies. For animals 413, 414, 415, and 416, the general
shift in energy was from a lower frequency to higher frequency;
for animal 412, this was reversed. In general, postoperatively, the
areas of maximum spectral energy were between 500 Hz and
1,000 Hz, whereas the baseline recordings generally had maxi-
mum energy below 500 Hz and above 100 Hz (Fig. 3D).
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Ex Vivo Assessment of the Explanted Seeded Graft
Due to limited contrast between the implanted seeded graft and
native tissue, it was not possible to image via CT the implanted
scaffold over the course of the study. However, following termi-
nation and explantation, each larynx underwent CT imaging to
identify and locate the seeded graft. In each animal, the thyroid
cartilage on the unoperated side was seen as a pitted sheet that
was partiallymissing from theopposite side. Continued growth of
this cartilage plate after surgery, without the counterbalancing
cartilage on the opposite side, resulted in a slight rotation along
the longitudinal axis toward the unoperated side, because the
midline axis of the laryngeal prominence and the cricoid cartilage
were no longer in alignment. In each case, distal to the laryngeal
prominence, the tissue underwent rapid growth; this was espe-
cially evident in animals 415 and 416. In no animal was the
intact implanted scaffold visible; however, in each case, white
fragments of varying sizes (identified histologically as decellular-
ized cartilage) of the scaffold could be seen; a static image is
presented in Figure 4A, and supplemental onlineVideo1presents
a 3D rotating view.
Although the implanted cartilaginous component showed
signs of fragmentation, the luminal mucosal surface showed sig-
nificant regeneration. In each explanted larynx, on the implanted
side, rudimentary vocal folds or straps had developed, extending
from the arytenoid cartilage anteriorly. Animals 414 and 416 had
well-defined straps of tissue, whereas animals 412, 413, 415, and
417 showed regenerated vocal folds. In each case, as visualizedon
bronchoscopy, these were positioned higher than those on the
opposite side. The size of the folds varied between animals (rep-
resentative images are presented in Fig. 4B, 4C).
Assessment of Epithelialization and
Cartilage Remodeling
Histologically, we could not identify the TE oral mucosal sheet in
any explanted seeded graft. Animal 417 was killed early because
of unrelated pathology; remnants of what might be the original
Figure 2. Evaluation of the decellularized porcine larynx using histological, molecular, and biomechanical analyses. Sections were stained with H&E
and compared against control tissue (A) for the absence of intact nuclear material within muscle (B), cartilage, and overlying collagen (C). Sections
were further stained with PSE-ME to illustrate intact elastin within the blood vessels (arrow) (D) and intact collagen fibers between the muscle
bundles (arrow) (E). (F): Under polarized light, the structural integrity of the collagen was further verified. Molecular analysis for the amount of
DNA, glycosaminoglycans (GAGs), and total collagen remaining within the decellularized larynx was undertaken for cartilage andmuscle indepen-
dently (mean6 SD; p value determined by 1-way analysis of variance with multiple comparisons; n = 6 for each group). Statistical analysis was
performed using Student’s t test, for which p, .05 was considered statistically significant. The molecular data for each were as follows: cartilage:
p,p= .0001;muscle:p,p= .0329 (G); cartilage:p,p= .0001;muscle:p,p= .1099 (not significant) (H); and cartilage:p,p= .002;muscle:p,p= .0001 (I).
(G–I):Bothdecellularizedcartilage (p, .05)andmuscle(p, .05)showedastatisticallysignificantreduction intheamountofDNA.Similarly, theamount
ofGAGs remainingwith thedecellularized cartilage (p, .05)was reducedbutpreservedwithin decellularizedmuscle tissue. Collagen contentwas also
significantly reduced in thedecellularizedcartilageandmuscle tissue (p, .05 foreach). Biomechanical analysis of thedecellularized tissuecomponents
onlyrevealedchangesfor themusclebutnotcartilage.Abbreviations:CA,cartilage;CO,collagen;DC,decellularized;DCvac,decellularizedusingvacuum
technology; H&E, hematoxylin and eosin stain; M, muscle; PSR-ME, Picrosirius red with Miller’s elastin; sGAG, sulfated glycosaminoglycan.
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seeded oral mucosal sheet could be identified, and appeared to
elicit an immune response. The remains of the sheet were sur-
rounded by a heavy inflammatory zone (Fig. 5A), the central
portion of which showed collagen fibrils accompanied by
considerable cellular debris (Fig. 6B), suggesting an adverse host
response to the seeded sheet. By 6 months, in each animal, the
mucosal surface on the operated side showed a contiguous epi-
thelial layer consistingof stratified squamousepithelium (Fig. 5C),
Figure3. In vivo assessment of the implanted decellularized larynxover theduration of the study. (A):Blood serum levels of both IL-6 and IL-10.
(B): Still bronchoscopy images at 2, 4, and 8weeks and 6months showing themucosal surface. Each operated side is illustratedwith an asterisk.
Mucosal brushing and the subsequent staining of cells with Ck-7 (left: normal human buccal cheek cells; second from left: mucosal brushing
from animal 415) and a-GAL (middle: human cheek cells; second from right: normal porcine cheek cells; right: mucosal brushing from animal
414). (D): A representative vocal recording profile (frequency vs. intensity) from animal 412. Abbreviation: IL, interleukin.
Figure 4. Ex vivo assessment of the implanted scaffold. (A): Static computed tomography image showing the remnants of the cartilage com-
ponent (markedwith an asterisk) of the decellularized scaffold; a three-dimensional rotating image is presented in supplemental online Video 1.
Representative images of the internal luminal surface showing good mucosal coverage and the development of a vocal fold (marked with an
asterisk) (B) and a vocal “strap” of tissue (C), both craniocaudally offset from the normal contralateral true vocal fold.
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withinwhichnocellswerepositive forAlu, confirming that all cells
were host derived (Fig. 5D).Within the lamina propria, numerous
blood vessels, both arterioles and venules of varying sizes (posi-
tive for a-SMA), were located, as were well-developed glandular
tissue (both serous and mucinous) (Fig. 5E). Occasionally, there
were either loose clusters of inflammatory cells (lymphoid aggre-
gate) or well-defined lymph node (i.e., mucosal associated lym-
phoid tissue) (Fig. 5F). In each animal, either a pseudo-vocal
fold (animals 412, 413, 415, and 417; Fig. 4G) or a strap of tissue
(animals 414 and 416; Fig. 5H) had developed. Histologically, it
was possible to distinguish between the regenerated vocal folds
and the incompletely regenerated vocal straps. The tips of the
folds showed signs of differentiation into more specialized cells
(Fig. 5I).
In all animals, the thyroid cartilage component of the scaffold
had displaced laterally from the original implanted site, probably
due to the persistent pull of the sternohyoid muscle used to pro-
vide revascularization. However, in animals 413, 414, and 416,
fragments of cartilage (thyroid and cricoid) from the original
implanted decellularized scaffold could be identified, but they
were remote from the initial surgically implanted site. In these
cases, fragments of the acellular scaffold were infiltrated with
different populations of cells surrounded by collagen fibrils,
indicating remodeling of the hyaline cartilage together with evi-
dence of angiogenesis.
In animal 413, therewas a lymphnode adjacent to the decel-
lularized thyroid cartilage (Fig. 6A) next to which was an area
of mineralization. However, this profile was not consistent
across 3 of the animals (413, 414, and 416). The remaining car-
tilage in animals 416 and 414 was again predominantly acellular
and there was little to no inflammatory response surrounding
the cartilage (Fig. 6B, 6C). Instead, therewas infiltration of fibro-
blast and macrophages into the implanted cartilage and small-
caliber blood vessels (stained with a-SMA) (Fig. 6D, 6E). The
ECM housing these cells consisted of collagen fibers rather
than cartilage, suggesting remodeling of the original implanted
tissue.
In animal 412, the original implanted acellular cartilage had
relocated and was slowly being remodeled into bone; this was
not the case in the remaining animals. In these animals the acel-
lular cartilage showed signs of remodeling with collagen fibers.
We probed the tissue for chondrocyte markers, both early; Colla-
gen II (expressed by both early and mature chondrocytes) and
CD 44 (cartilage homeostasis) and late collagen X (hypertrophic
chondrocytes) (Fig. 6F–6H). In acellular cartilage not undergoing
ossification, we found cells positive for aggrecan, indicating the
Figure 5. Epithelialization and mucosal coverage. (A): Remains of the tissue-engineered oral mucosal sheet from animal 417 showing a con-
centration of inflammatory cells (insert) surrounding amineralized center. (B): The collagen fibers of the original decellularized dermal collagen
sheet (arrowheads) aremore easily identifiable on the Picrosirius redwithMiller’s elastin-stained section. In this image, the sheet has folded on
itself and the paler central portion represents the original seeded aspect. Epithelialization of the mucosal surface showing stratified columnar
epithelium (C) of porcine origin (insert shows positive stained human small intestine) (D). (E): The underlying mucosa shows well established
vasculature (a-SMA stain). Both vocal folds (G) and strap (H) were identified histologically. (I): Tips of the vocal folds. Abbreviations: M, min-
eralized; vf, vocal fold; vs, vocal strap.
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initiation of chondrogenesis (Fig. 6I), in turn indicating the poten-
tial changes in the load-bearing capability of the decellularized
scaffolds. The fate of the seeded human BM-MSCs could not be
determined.
DISCUSSION
This studywas designed to provide long-termevidence of safety
and efficacy (i.e., no long-term physiological or functional im-
pact) of a seeded decellularized scaffold for partial laryngeal re-
placement, with data suitable for submission for the award of a
Clinical Trials Authorization (the U.K. equivalent of an Investiga-
tional New Drug in the U.S.). Through the nature of the target,
unmet clinical need, and because our present grafts do not
exhibit mobility, this study was not designed to replace a fully
functional larynx but to assess whether a tissue-engineered,
full-thickness partial laryngeal replacement could eventually
be used to correct structural disorders. We have shown that
it is possible to produce a biocompatible biological scaffold
that has the potential to promote re-epithelialization and sub-
mucosal regeneration. More importantly, it can provide the
framework tomaintain normal respiratory function, and appro-
priate swallowing and vocalization.
Previous tissue-engineering strategies have used a scaffold-
based approach, with and without cell seeding, to restore struc-
ture and function. Decellularized scaffolds have been increasingly
used in preclinical and clinical studies including the airway with
some success [10, 11]. Decellularization of the larynx has been re-
ported using numerousmethods, including enzymebased [8], en-
zymatic and detergent combinations [14], detergents combined
with perfusion techniques [15], and freeze drying and sonication
[16] for a number of different species. However, the use of neg-
ative pressure combinedwith hyper- and hypotonic solutions fol-
lowed by enzymatic/detergents has not, to our knowledge, been
previously reported. The introduction of negative pressure is
likely to assist in drawing the reagents deeper into tissue more
quickly and limit the damaging effects of the detergents and en-
zymes on the ECM. This approach took 8 days to produce a scaf-
fold; a similar outcome was not possible in the same time
frame if negative pressure was omitted. The enzyme-based
protocol used by Baiguera et al. [14] to decellularize a human
larynx (similar in size to the pig) took considerably longer (25
cycles took longer than 2 weeks) and, therefore, our approach
represents a potential financial savings and increases the pos-
sibility of producing a tailor-made, off-the-shelf scaffold for la-
ryngeal replacement.
Figure 6. Cartilage remodeling. (A):Decellularized cartilage showing infiltration by a lymph node andmineralization, resulting in degradation.
(B, C): This profile was not consistent across all animals; in some cases, the acellular cartilage was infiltratedwith cells (arrows). (D): In addition,
where cells had infiltrated the acellular cartilage, the cartilagewas slowly remodeled into collagen fibrils (arrow). (E):Where cartilagewas being
remodeled, as in animal 412, the original decellularized cartilage had established blood vessels (stained with a-SMA; arrows) and cells positive
for collagen II (F; insert shows cytoplasmic positivity of a cell at higher magnification) CD 44 (G; insert shows a cell at highermagnification), and
collagen X (H; cytoplasmic positive cell within the extracellularmatrix). (I): Potential load-bearing changes in the cartilagewere illustrated by the
presence of aggrecan cytoplasmic positive cells. Abbreviations: c, cartilage; ln, lymph node; m, mineralization.
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In line with published studies, we have shown complete
decellularization of the larynx with no disruption to tissue
architecture andmorphology, andwith preservation of the col-
lagen and elastin within the soft tissue and cartilage. However,
the reduction in cartilage GAG content is likely to have contrib-
uted to the degradation and loss ofmechanical durability of the
thyroid and cricoid cartilage when implanted. The Blyscan Bio-
color GAG assay does not give an indication of the structural
integrity of the GAGs following decellularization (it simply
gives the amount of sulfated GAGs) and, therefore, may not
be appropriate as a proxy indicator of potential cartilage bio-
mechanics in vivo. Additionally, we observed no alteration in
tensile strength and rupture force for decellularized cartilage
(similar to the reported human decellularized larynx [14]),
yet within 6 months, significant amounts of cartilage had
degraded.
To date, implantation of fully tissue-engineered larynx has
not been undertaken, although human-to-human full laryngeal
transplants have been successfully attempted [17]. Implanta-
tions of vocal folds in a rat model using either a decellularized
scaffold [8] or a multilaminar urinary bladder-based ECM have
been reported [18]. Additionally, a porcine-derived multilami-
nate ECM has been used for laryngeal reconstruction in dogs,
resulting in cell- and tissue-specific regeneration [19]. In vivo
studies in a large-animal model using decellularized laryngeal
scaffolds are limited. However, a submucosal placement of
decellularized arytenoid into the body of the arytenoid in an
equine model has been undertaken for 1 month [20]. The au-
thors reported no impact on respiratory function or swallowing
during the course of the study, but the animal did remain intu-
batedwith a tracheostomy tube for 3weeks of the 4-week study
(we did not intubate any animal postoperatively). Histological
evaluation of the explanted tissue showed epithelialization
accompanied by evidence of new hyaline cartilage formation
but also complete degradation of the original decellularized
scaffold.
In our study, we had a survival rate of greater than 80%: 5 of 6
pigs survived to planned death. The tissue-engineered epithelial
sheet could not be identified on bronchoscopic evaluation, al-
though regeneration of themucosal surface occurred in every an-
imal. The lack of established vasculaturemay have contributed to
theepitheliumbecomingnecrotic anddetached from the surface,
andeither coughedout or swallowedby the animal. However, the
unplanned killing of 1 animal at 2 months postimplantation pro-
vided valuable information. Given that, the tissue-engineered
epithelial sheet in this pig could only be identified by the sur-
rounding inflammatory reaction, yet an epithelial coverage
had developed histologically. We hypothesize that it may
not be necessary to use a tissue-engineered epithelial sheet
to promote re-epithelialization. The previously reported equine
study [20] also showed epithelial coverage without the use of
a re-epithelialization adjunct. However, comparison of adipose-
derived mesenchymal seeded and nonseeded tracheal scaffolds
in rodents suggested accelerated re-epithelialization [21], which
is vital because airway tissue is prone to infection and mucous re-
tention [22, 23].
Phonatory recordings showed changes in frequency and en-
ergy, but statistical correlation with morphological outcomes
were difficult. Additionally, the lack of long-term control data
made interpretation of changes arising due to normal growth
and development difficult; this is also the first time, to our
knowledge, that pig vocalization has been objectively mea-
sured, sowe lack normal reference ranges. Althoughwenoticed
an appreciable qualitative change in the tone of vocalization at
the end of the study, it was impossible to determine howmuch
of the vocalization was due to contribution from the unoper-
ated side and how much was from the development of the
new “pseudo” folds. Physical attributes relating to vocalization
(e.g., “intensity, fundamental frequency, signal periodicity and
harmonic to noise ratio” [24]) rely on composition andmechan-
ical stability of the tissue required to produce sound. It is pos-
sible that by keeping the decellularized vocal folds under
constant tension (improved surgical attachment) andmaintain-
ing symmetrical height of the cords, we might have achieved
a better anatomical outcome regarding both the positioning
of the newly regenerated vocal folds and their anatomical
appearance.
The cartilaginous component of the scaffold did not remain in
its original anatomical craniocaudal location, due to either inad-
equate surgical retention or the additional tension caused by the
sternothyroid muscle. In only one animal (pig 412) did we see ev-
idence of ossification at the cut end of the native cartilage accom-
panied by vascularization within the decellularized cartilage. In
this sample, within the decellularized component, we found cells
positive for collagen type X,which is a characteristic feature of hy-
pertrophic chondrocytes that play a pivotal role in endochondral
ossification. During this process, a coordinated chain of events,
starting with chondrocyte proliferation, maturation, and hyper-
trophy, takes place. In the latter stage, the hypertrophic cartilage
undergoes calcification, there is an influx of vasculature, and the
cartilage is slowly replaced by a bonymatrix [25]. However, endo-
chondral ossification in human laryngeal cartilage has been docu-
mented [26]; in contrast to endochondral ossification in growth
plates, the hypertrophic chondrocytes and the resultant mineral-
ized cartilage is not readily reabsorbed and can remain for many
years [27].
In the acellular cartilage, we found few chondrocytes posi-
tive for both collagen II and aggrecan. The main proteoglycan
secreted by chondrocytes is aggrecan and it provides the
load-bearing and compressive characteristics of cartilage. Col-
lagen II is the major collagen secreted by chondrocytes and is
specific for cartilage, where it provides the tensile strength re-
quired by this tissue. Cells positive for type II collagen are usu-
ally proliferating and differentiated chondrocytes [28, 29].
Taken together, we hypothesize that the acellular cartilage,
given time, would remodel as cartilage rather than bone, but
the long-term regenerative pathway is unknown. However,
we did not probe for osteoblastic progenitor because we had
not considered the possibility that the acellular cartilage would
remodel as bone; we felt that the time frame would be too
short. Additionally, the presence of cells positive for CD44 also
suggests that acellular cartilage is being remodeled back into
active tissue. CD44, together with integrin b 1, allows chondro-
cytes to function as mechanotransducers; as such, these recep-
tors play a crucial role maintaining cartilage homeostasis
[30]. Our analysis of the acellular cartilage component of the
implanted decellularized larynx is by no means comprehensive
but merely an exploration of possible events likely to be taking
place. Future work would need to concentrate on whether
changes in the decellularized cartilage was initiated in response
to the seeded mesenchymal stem cells or is purely a host-
derived progenitor cellular response.
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CONCLUSION
Patients who have had treatment for laryngeal cancer or the af-
termath of trauma may be left with severe morbidity relating to
swallowing, vocalization, and respiratory function; conventional
therapies to address such structural disorders are suboptimal.
This study was designed to provide long-term evidence of safety
and efficacy of a TE-seeded decellularized scaffold for partial
laryngeal replacement.Wehave shown that it is possible todecel-
lularize an entire larynx and produce a biological scaffold that is
safe and biocompatible, and has the potential to promote re-
epithelialization and submucosal formation. More importantly,
our implanted scaffold provided the framework to maintain nor-
mal respiratory function together with appropriate swallowing
and vocalization.
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